About Me

Emmanuel Sleiman

Medical Doctor in Training | Health & AI MSc Student

Researcher trainee in Myeloma Genomics & Immunology at Inserm, Toulouse Cancer Research Center

Education

Doctor of Medicine, Faculty of Medicine, University of Burgundy ~ Dijon - France, June 2024

Prognostic impact of MRD predicted by machine learning for patients with myeloma eligible for autologous transplantation

University of Burgundy ~ Dijon - France, September 2024 to present

Second Msc degree. in Health and Artifical Intelligence

Dijon University Hospital, University of Burgundy ~ Dijon - France, November 2020 to present

Medical Residency, Clinical Hematology – Blood Diseases

University of Aix-Marseille ~ Marseille - France, June 2020

National Ranking Exam (ECN) rank 4466th

University of Aix-Marseille ~ Marseille - France, June 2017

First Msc degree. in Quantitative and Econometric Methods for Health Research

University of Aix-Marseille ~ Marseille - France, June 2015

First-year medical school rank 25th

Chevreul Blancarde High School ~ Marseille - France, June 2014

French HS diploma, Science major with highest honors. Specialization in Physics – Chemistry and Life Earth Sciences

Publications

Innovant immunotherapy for relapsed/refractory Hodgkin Lymphoma (rrHL)

<u>Emmanuel Sleiman</u> et al.

*_Rev Immunité et Cancer_, 2021, 5 (3)*

Prognostic value of post-induction medullary myeloid recovery by flow cytometry in acute myeloid leukemia

Céline Row, Nicolas Lechevalier, Jean-Philippe Vial, Aguirre Mimoun, Jean-Noël Bastie, Denis Caillot, <u>Emmanuel Sleiman</u>, et al.

*_Research Square_ (Preprint), April 2023*

Long-term outcome after autologous BCR::ABL1-negative peripheral blood stem cell transplantation in adults with Philadelphia-positive acute lymphoblastic leukemia: a comparative study

Leo Caillot, Mathieu Leclerc, <u>Emmanuel Sleiman</u>, et al.

*_Haematologica_, Nov 2023*

Early CAR-T Cells expansion is associated with prolonged PFS for patients with RRMM treated with ide-cel: a retrospective monocentric study

Leo Caillot, <u>Emmanuel Sleiman</u>, et al.

*_Transplantation and Cellular Therapy_, March 2024*

Medical Career

Universiy of Aix-Marseille
~ First and Second Cycles of Medical Studies, Marseille - France

University of Burgundy
~ Third Cycle of Medical Studies: Medical Residency, Dijon - France

Core Phase:

Clinical Hematology ~ Dijon - France, November 2020 ~ April 2021
Dr. CAILLOT, Dijon University Hospital
Clinical Hematology ~ Dijon - France, May 2021 – October 2021
Dr. CAILLOT, Dijon University Hospital

Consolidation Phase:

Clinical Hematology ~ Dijon - France, November 2021 – April 2022
Dr. CAILLOT, Dijon University Hospital
Clinical Hematology ~ Dijon - France, May 2022 – October 2022
Dr. CAILLOT, Dijon University Hospital
Biological Hematology ~ Dijon - France, November 2022 – April 2023
Prof. MAYNADIE, Dijon University Hospital
Medical Intensive Care ~ Dijon - France, May 2023 – October 2023
Prof. QUENOT, Dijon University Hospital

Advanced Phase:

Hematopoietic Stem Cell Transplantation ~ Paris - France, November 2023 – April 2024
Prof. PEFFAULT DE LATOUR, Saint-Louis Hospital, APHP
Nephrology ~ Dijon - France, May 2024 – November 2024
Dr. ZANETTA, Dijon University Hospital

Additional Training

RCP209 – Statistical Learning: Decision Modeling and Deep Learning
~ Paris - France, 2023-2024

Prof. Arnaud Breloy, National Conservatory of Arts and Crafts - Completed

DU REAMID (Critical Care for Immunocompromised Patients)
~ Paris - France, 2022-2023

Prof. Elie Azoulay, Saint-Louis Hospital, APHP Paris. University of Paris Cité – Completed

ESH Immune & cellular therapies : Focus on Advanced Gene-Engineered Immune Cells ~ Dublin - Ireland, 2024

Chairs : Chiara Bonini (Milan), Michael Hudecek (Würzburg), Stanley Riddell (Seattle)- Completed

INSERM Workshop (Massive Omics Data : Statistical and Bioinformatic Advances) ~ Bordeaux - France, 2024

Chairs : Christel Depienne (Essen), Inês Barroso (Exeter), Simone Rubinacci (Boston)- Completed

Research Experience

Intern – Genomics and Immunology of Myeloma Unit ~ INSERM, Toulouse, France | February 2025 to present

Under the supervision of Prof. Hervé Avet-Loiseau and Prof. Jill Corre

| Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination (ResisTec)

Skills

Programming Languages: \(\LaTeX\), Python, R, MATLAB

Tools and Frameworks: GitHub, PyTorch, TensorFlow, CoCalc

Languages: Français and Italiano (native), English and Deutsch (fluent)